Abivax SA (ABVX) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of Abivax SA stock €27.92, price €63.00, that is 55.7% below the price, quality 26 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently applies, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Abivax SA
ABVX · PAFar too expensive (fair value 56% below the price), weak company and falling price: meets none of the 3 rules.
Main risks:
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 21, 2026.
How to read this chart
60‑month range €4.56 – €135.00 · fair‑value band €20.94 – €34.90 · the €63.00 price screens above the €27.92 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 21, 2026.
Every Wednesday you see whether Abivax is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
ABIVAX, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
Show moreShow less
Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Stock analysis
Abivax SA (ABVX) currently trades at €63.00, while our estimate is €27.92, 56% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently applies to this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: €20.94 (bear) to €34.90 (bull), the price of €63.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 26/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Abivax SA reported revenue of €0 in FY2025 versus €37.0K in FY2021. Reported net income was −€336M in FY2025.
Key figures
Market cap €5.5B Mid · EPS (TTM) €-5.21 · Return on equity −252% · Return on assets (EBIT) −61.6% (5-year average) · Operating margin −6,270% · Revenue (TTM) €4.7M · Revenue growth (quarter YoY) −6.8% · Free cash flow −€162M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (low confidence).
What moves the price
The share trades about 53% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −56%, ABVX screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Abivax SA with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 856 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EBIT margin by industry
- P/S ratio by industry
- PEG screener for stocks with fair value
- Undervalued stocks: French Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $920.69 | $1,275.02 | +38% | vs ABVX |
| Vertex Pharmaceuticals Incorporated VRTX | $515.02 | $566.52 | +10% | vs ABVX |
| Samsung Biologics Co 207940 | ₩1,355,000 | ₩1,490,500 | +10% | vs ABVX |
| argenx SE ARGX | $925.70 | $908.40 | −2% | vs ABVX |
| CSL Limited CSL | A$197.29 | A$188.80 | −4% | vs ABVX |
| BeOne Medicines AG 6160 | HK$230.80 | HK$152.92 | −34% | vs ABVX |
| Moderna, Inc MRNA | $195.00 | $122.98 | −37% | vs ABVX |
| Revolution Medicines, Inc RVMD | $161.20 | $83.14 | −48% | vs ABVX |
| Celltrion, Inc 068270 | ₩213,000 | ₩74,574 | −65% | vs ABVX |
| Royalty Pharma plc RPRX | $68.45 | $19.01 | −72% | vs ABVX |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Abivax SA (ABVX) overvalued or undervalued?
What is the fair value of ABVX?
What is the quality score of ABVX?
What is the price target for Abivax SA (ABVX)?
What is the Abivax SA stock forecast for 2026?
What is the revenue of Abivax SA (ABVX)?
What is the intrinsic value of Abivax SA (ABVX)?
Is Abivax SA stock overvalued or undervalued in 2026?
Is fair value the same as the market price of ABVX?
How much is Abivax SA worth?
What do the bullish and bearish scenarios say about ABVX?
How solid is the balance sheet of Abivax SA (ABVX)?
How far is ABVX from its 52-week high?
Which stocks are comparable to Abivax SA?
Is Abivax SA stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Abivax SA (ABVX)?
What should I pay attention to with Abivax SA right now?
Key figures of Abivax SA
How large is the market capitalisation of Abivax SA (ABVX)?
What are the earnings per share of Abivax SA (ABVX)?
What is the return on equity of Abivax SA (ABVX)?
What is the EBIT return on assets of Abivax SA (ABVX)?
What is the operating margin of Abivax SA (ABVX)?
How fast is revenue growing at Abivax SA (ABVX)?
How much free cash flow does Abivax SA (ABVX) generate?
How much net cash does Abivax SA (ABVX) hold?
Watch Abivax SA in the live analysis
One click puts Abivax SA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.